U.S. Stock Futures Generally Lower, Market Sentiment Cautious
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MASI?
Stock futures are generally trading lower, reflecting renewed concerns about artificial intelligence-related disruption after last week's weakness in tech and software stocks. Markets are broadly softer and tilted toward risk-off sentiment as stocks reopen following the long Presidents' Day weekend.Beyond the U.S., European markets have managed to hold up somewhat better, with indexes like the STOXX 600 trading modestly higher as investors balance geopolitical developments with sector-specific earnings strength across areas such as healthcare and utilities. In Asia, markets that were open during the U.S. holiday session showed mixed moves as well, with Indian benchmarks sliding modestly and broader flows influenced by global risk signals.In pre-market trading, S&P 500 futures fell 0.44%, Nasdaq futures fell 0.87% and Dow futures fell 0.25%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Masimoup 35% after entering into a definitive agreement pursuant to which Danaherwill acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9BZIM Integratedup 35% after announcing a merger agreement, under which Hapag-Lloyd will acquire the company for $35.00 per share in cashNorwegian Cruise Lineup 7% after WSJactivist investor Elliot has built an over 10% stake in the companyFiserv (FISV) up 3% after The Wall Street Journalactivist investor Jana Partners has built a stakeWarner Bros. Discoveryup 2% after announcing that Netflixhas provideda limited waiver under the terms of Warner Bros. Discovery's merger agreement, permitting the company to engage in discussions with Paramount Skydancefor a seven-day period ending on February 23 to seek clarity and provide Paramountthe ability to make its best and final offerUP AFTER EARNINGS -Labcorpup 1%DOWN AFTER EARNINGS -Leidosdown 3%Medtronicdown 2%LOWER -Danaherdown 6% after entering into a definitive agreement to acquire MasimoGeneral Millsdown 3% after cutting its FY26 outlook ahead of the company's CAGNY update
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MASI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MASI
Wall Street analysts forecast MASI stock price to rise
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 130.150
Low
162.00
Averages
188.40
High
210.00
Current: 130.150
Low
162.00
Averages
188.40
High
210.00
About MASI
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Danaher to Acquire Masimo for $9.9 Billion
- Acquisition Overview: Danaher announced an all-cash acquisition of Masimo for approximately $9.9 billion, paying $180 per share, reflecting about 18 times Masimo's projected 2027 EBITDA, with the deal expected to close in the second half of 2026.
- Earnings Growth Expectations: Danaher anticipates the acquisition will add between $0.15 and $0.20 to adjusted earnings per share in the first full year post-closing, with contributions expected to rise to approximately $0.70 per share by year five, indicating significant long-term growth potential.
- Business Integration and Synergies: Masimo will operate as a standalone business within Danaher’s Diagnostics unit, with expectations of capturing over $125 million in annual cost efficiencies and more than $50 million in annual revenue synergies within five years, enhancing competitive positioning.
- Market Reaction and Investor Sentiment: Following the acquisition announcement, Danaher’s stock fell over 6%, while Masimo’s stock surged over 34% in premarket trading, reflecting a shift to extremely bullish sentiment around Masimo's future prospects.
See More
Warner Bros. Discovery and Paramount Skydance Deal Talks
- Stock Price Surge: Shares of Warner Bros. Discovery rose 2.4% and Paramount Skydance jumped nearly 4% after Netflix granted a seven-day waiver for deal talks, reflecting market optimism about a potential transaction between the two media giants.
- Acquisition Rumors: Health tech leader Masimo's shares surged over 33% following reports from The Wall Street Journal and Financial Times that it is nearing a $10 billion acquisition deal with Danaher at $180 per share, indicating strong market interest in the deal.
- Earnings Beat: DTE Energy Company saw its shares increase by 2% after reporting fourth-quarter and fiscal year 2025 earnings that exceeded expectations, although its 2026 guidance was at the lower end of forecasts, suggesting cautious sentiment about future performance.
- Investor Activity: Norwegian Cruise Line Holdings' stock rose 7.5% after reports indicated that Elliott Investment Management has acquired over a 10% stake and plans to advocate for changes to improve the company's performance, highlighting investor focus on its future direction.
See More
S&P 500 Futures Decline in Pre-Market Session; Masimo and Enlight Renewable Energy Take the Lead
- Masimo Corp. Performance: Masimo Corp. (MASI) saw a significant increase of 34.5% in pre-market trading.
- Enlight Renewable Energy Ltd. Performance: Enlight Renewable Energy Ltd. (ENLT) experienced an 8.0% rise in pre-market trading.
- Market Context: The U.S. stock markets are set to open in two hours, indicating potential volatility.
- Investor Sentiment: The pre-market gains for both companies suggest positive investor sentiment ahead of the market opening.
See More
U.S. Stock Futures Fluctuate Amid Government Shutdown Impact
- Market Fluctuations: U.S. stock futures showed volatility on Tuesday following a mixed close on Friday, with the S&P 500 down 1.4%, the Dow slipping 1.2%, and the Nasdaq declining 2.1% last week, reflecting cautious investor sentiment amid uncertainty.
- Government Shutdown Impact: The failure of Congressional Democrats and the Trump administration to reach a funding deal through September has triggered a partial government shutdown, which could exacerbate market instability and undermine investor confidence.
- Bond Yields: The 10-year Treasury bond yield stands at 4.02%, while the two-year bond yield is at 3.39%, indicating market expectations for future interest rate policies, with the CME Group's FedWatch tool showing a 90.2% likelihood of rates remaining unchanged in March.
- Stock Performance: Ocular Therapeutix's stock surged 33.56% ahead of its clinical trial data release for dry eye disease, while ZIM Integrated Shipping Services rose 34.46% following its acquisition agreement with Hapag-Lloyd, highlighting positive market reactions in specific sectors.
See More
Danaher Nears $9.9 Billion Acquisition of Masimo Corp.
- Acquisition Progress: Danaher is reportedly nearing a $9.9 billion acquisition of Masimo, representing a notable premium over Masimo's nearly $7 billion market cap, with an announcement expected as early as Tuesday, barring any last-minute complications.
- Governance Changes Context: This acquisition follows significant governance changes at Masimo driven by activist investors, leading to the removal of founder Joe Kiani as board chair, who retains about a 5% stake, highlighting the strong influence of investors on corporate strategy.
- Financial Performance Comparison: Danaher reported fourth-quarter 2025 sales of $6.84 billion, up 4.5% year-over-year and beating market expectations, while Masimo anticipates fiscal 2025 sales of approximately $1.523 billion, indicating a disparity in market performance between the two companies.
- Market Reaction: Following the acquisition news, Danaher's shares fell 5.22% in premarket trading, while Masimo's shares surged 34.51%, reflecting differing market expectations regarding the potential impact of the acquisition.
See More
This Medical Devices Company Is Rising Rapidly and May Be Targeted for Acquisition.
- Masimo's Stock Surge: Masimo shares experienced a significant increase early on Tuesday.
- Acquisition News: The rise in stock price is attributed to reports that Masimo is nearing an acquisition by Danaher.
See More
Danaher to Acquire Masimo for $9.9 Billion
- Acquisition Overview: Danaher announced an all-cash acquisition of Masimo for approximately $9.9 billion, paying $180 per share, reflecting about 18 times Masimo's projected 2027 EBITDA, with the deal expected to close in the second half of 2026.
- Earnings Growth Expectations: Danaher anticipates the acquisition will add between $0.15 and $0.20 to adjusted earnings per share in the first full year post-closing, with contributions expected to rise to approximately $0.70 per share by year five, indicating significant long-term growth potential.
- Business Integration and Synergies: Masimo will operate as a standalone business within Danaher’s Diagnostics unit, with expectations of capturing over $125 million in annual cost efficiencies and more than $50 million in annual revenue synergies within five years, enhancing competitive positioning.
- Market Reaction and Investor Sentiment: Following the acquisition announcement, Danaher’s stock fell over 6%, while Masimo’s stock surged over 34% in premarket trading, reflecting a shift to extremely bullish sentiment around Masimo's future prospects.
See More
Warner Bros. Discovery and Paramount Skydance Deal Talks
- Stock Price Surge: Shares of Warner Bros. Discovery rose 2.4% and Paramount Skydance jumped nearly 4% after Netflix granted a seven-day waiver for deal talks, reflecting market optimism about a potential transaction between the two media giants.
- Acquisition Rumors: Health tech leader Masimo's shares surged over 33% following reports from The Wall Street Journal and Financial Times that it is nearing a $10 billion acquisition deal with Danaher at $180 per share, indicating strong market interest in the deal.
- Earnings Beat: DTE Energy Company saw its shares increase by 2% after reporting fourth-quarter and fiscal year 2025 earnings that exceeded expectations, although its 2026 guidance was at the lower end of forecasts, suggesting cautious sentiment about future performance.
- Investor Activity: Norwegian Cruise Line Holdings' stock rose 7.5% after reports indicated that Elliott Investment Management has acquired over a 10% stake and plans to advocate for changes to improve the company's performance, highlighting investor focus on its future direction.
See More
S&P 500 Futures Decline in Pre-Market Session; Masimo and Enlight Renewable Energy Take the Lead
- Masimo Corp. Performance: Masimo Corp. (MASI) saw a significant increase of 34.5% in pre-market trading.
- Enlight Renewable Energy Ltd. Performance: Enlight Renewable Energy Ltd. (ENLT) experienced an 8.0% rise in pre-market trading.
- Market Context: The U.S. stock markets are set to open in two hours, indicating potential volatility.
- Investor Sentiment: The pre-market gains for both companies suggest positive investor sentiment ahead of the market opening.
See More
U.S. Stock Futures Fluctuate Amid Government Shutdown Impact
- Market Fluctuations: U.S. stock futures showed volatility on Tuesday following a mixed close on Friday, with the S&P 500 down 1.4%, the Dow slipping 1.2%, and the Nasdaq declining 2.1% last week, reflecting cautious investor sentiment amid uncertainty.
- Government Shutdown Impact: The failure of Congressional Democrats and the Trump administration to reach a funding deal through September has triggered a partial government shutdown, which could exacerbate market instability and undermine investor confidence.
- Bond Yields: The 10-year Treasury bond yield stands at 4.02%, while the two-year bond yield is at 3.39%, indicating market expectations for future interest rate policies, with the CME Group's FedWatch tool showing a 90.2% likelihood of rates remaining unchanged in March.
- Stock Performance: Ocular Therapeutix's stock surged 33.56% ahead of its clinical trial data release for dry eye disease, while ZIM Integrated Shipping Services rose 34.46% following its acquisition agreement with Hapag-Lloyd, highlighting positive market reactions in specific sectors.
See More
Danaher Nears $9.9 Billion Acquisition of Masimo Corp.
- Acquisition Progress: Danaher is reportedly nearing a $9.9 billion acquisition of Masimo, representing a notable premium over Masimo's nearly $7 billion market cap, with an announcement expected as early as Tuesday, barring any last-minute complications.
- Governance Changes Context: This acquisition follows significant governance changes at Masimo driven by activist investors, leading to the removal of founder Joe Kiani as board chair, who retains about a 5% stake, highlighting the strong influence of investors on corporate strategy.
- Financial Performance Comparison: Danaher reported fourth-quarter 2025 sales of $6.84 billion, up 4.5% year-over-year and beating market expectations, while Masimo anticipates fiscal 2025 sales of approximately $1.523 billion, indicating a disparity in market performance between the two companies.
- Market Reaction: Following the acquisition news, Danaher's shares fell 5.22% in premarket trading, while Masimo's shares surged 34.51%, reflecting differing market expectations regarding the potential impact of the acquisition.
See More
This Medical Devices Company Is Rising Rapidly and May Be Targeted for Acquisition.
- Masimo's Stock Surge: Masimo shares experienced a significant increase early on Tuesday.
- Acquisition News: The rise in stock price is attributed to reports that Masimo is nearing an acquisition by Danaher.
See More
